Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TDC Technology Dedicated to Care is an Italian biotechnology and medical device company specializing in the development and manufacture of innovative products using liposomal technology. The company focuses on the therapeutic applications of lactoferrin, particularly in its liposomal form, to enhance bioavailability and efficacy across various medical fields. Its product portfolio includes treatments for ophthalmology (Somilux), dermatology (Kelapher), gynecology (Gyno-Apolact), and functional supplementation. TDC operates as both an innovator and a contract manufacturer (CDMO), with a presence in over 10 countries and a strong emphasis on research-driven solutions for unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology Dedicated to Care.